14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.640 $1.07 Thursday, 2nd May 2024 CTXR stock ended at $0.707. This is 2.66% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 10.29% from a day low at $0.680 to a day high of $0.750.
90 days $0.600 $1.07
52 weeks $0.600 $1.45

Historical Citius Pharmaceuticals Inc prices

Date Open High Low Close Volume
Feb 21, 2024 $0.740 $0.780 $0.740 $0.770 387 682
Feb 20, 2024 $0.770 $0.775 $0.727 $0.750 862 069
Feb 16, 2024 $0.85 $0.86 $0.770 $0.795 1 205 619
Feb 15, 2024 $0.779 $0.84 $0.760 $0.84 1 027 986
Feb 14, 2024 $0.740 $0.781 $0.710 $0.772 1 008 195
Feb 13, 2024 $0.716 $0.744 $0.670 $0.680 750 680
Feb 12, 2024 $0.629 $0.739 $0.629 $0.717 1 115 000
Feb 09, 2024 $0.604 $0.670 $0.604 $0.658 542 848
Feb 08, 2024 $0.615 $0.630 $0.605 $0.612 530 125
Feb 07, 2024 $0.607 $0.635 $0.600 $0.612 535 656
Feb 06, 2024 $0.600 $0.620 $0.600 $0.610 670 857
Feb 05, 2024 $0.630 $0.650 $0.600 $0.600 667 125
Feb 02, 2024 $0.640 $0.650 $0.622 $0.626 346 199
Feb 01, 2024 $0.630 $0.650 $0.623 $0.637 602 606
Jan 31, 2024 $0.628 $0.642 $0.621 $0.621 431 472
Jan 30, 2024 $0.690 $0.720 $0.625 $0.625 794 934
Jan 29, 2024 $0.678 $0.722 $0.650 $0.669 1 486 202
Jan 26, 2024 $0.670 $0.688 $0.660 $0.680 302 497
Jan 25, 2024 $0.630 $0.683 $0.630 $0.653 497 533
Jan 24, 2024 $0.674 $0.680 $0.605 $0.640 1 397 709
Jan 23, 2024 $0.700 $0.709 $0.661 $0.674 786 371
Jan 22, 2024 $0.720 $0.739 $0.670 $0.700 917 474
Jan 19, 2024 $0.760 $0.760 $0.720 $0.721 673 232
Jan 18, 2024 $0.780 $0.790 $0.735 $0.750 1 376 481
Jan 17, 2024 $0.750 $0.781 $0.735 $0.765 843 080
Click to get the best stock tips daily for free!

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected c... CTXR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT